Jennison Associates
GWPH

Jennison Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Jennison Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-186,760
Closed -$21.6M – 757
2020
Q4 		$21.6M Buy
186,760
+30,090
+19% +$3.37M 0.02% 330
2020
Q3 		$15.3M Buy
+156,670
New +$18M 0.01% 335
2019
Q4 		– Sell
-269,865
Closed -$31M – 694
2019
Q3 		$31M Sell
269,865
-169,090
-39% -$25.7M 0.03% 255
2019
Q2 		$75.7M Buy
438,955
+57,210
+15% +$9.9M 0.08% 150
2019
Q1 		$64.4M Sell
381,745
-133,536
-26% -$19.9M 0.06% 186
2018
Q4 		$50.2M Buy
515,281
+145,227
+39% +$19.1M 0.06% 206
2018
Q3 		$63.9M Sell
370,054
-105,779
-22% -$15.3M 0.06% 217
2018
Q2 		$66.4M Sell
475,833
-62,460
-12% -$8.87M 0.06% 216
2018
Q1 		$60.6M Buy
538,293
+48,403
+10% +$6.09M 0.06% 228
2017
Q4 		$64.7M Sell
489,890
-2,590
-0.5% -$304K 0.06% 227
2017
Q3 		$50M Buy
492,480
+1,759
+0.4% +$188K 0.05% 272
2017
Q2 		$49.2M Buy
490,721
+24,376
+5% +$2.62M 0.05% 268
2017
Q1 		$56.4M Buy
466,345
+316,926
+212% +$38.9M 0.06% 246
2016
Q4 		$16.7M Buy
149,419
+461
+0.3% +$55.5K 0.02% 431
2016
Q3 		$19.8M Buy
148,958
+71,087
+91% +$6.79M 0.02% 412
2016
Q2 		$7.13M Buy
+77,871
New +$6.55M 0.01% 485
2015
Q4 		– Sell
-192,343
Closed -$17.6M – 757
2015
Q3 		$17.6M Sell
192,343
-31,462
-14% -$3.5M 0.02% 451
2015
Q2 		$27.5M Sell
223,805
-80,391
-26% -$9.12M 0.03% 423
2015
Q1 		$27.7M Buy
304,196
+45,282
+17% +$3.68M 0.03% 406
2014
Q4 		$17.5M Buy
+258,914
New +$18.9M 0.02% 448
2014
Q3 		– Sell
-199,316
Closed -$21.4M – 763
2014
Q2 		$21.4M Buy
199,316
+8,743
+5% +$608K 0.02% 425
2014
Q1 		$11.3M Buy
+190,573
New +$11.3M 0.01% 484

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates's GWPH Position: Q1 2021 in Review

Jennison Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 186,760 shares — an estimated $21.6M sold.

Jennison Associates first reported a position in GWPH in Q1 2014 and held it in 22 quarters. The position peaked at $75.7M in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Jennison Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Jennison Associates sold 186,760 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $21.6M.
  • Jennison Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 22 quarters.
  • Jennison Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $75.7M in Q2 2019.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Jennison Associates's 13F filing for Q1 2021, filed 11 May 2021.